ENOB insider filings

Enochian Biosciences Inc — 44 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-08-01. Screen ENOB transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for ENOB between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Enochian Biosciences Inc

FiledFormInsiderReported transactionsSource
2023-08-014Sindlev Rene — Director, 10% ownerGrant/award (A): 131,579 (derivative) @ $0EDGAR
2023-06-274Sindlev Rene — Director, 10% ownerGrant/award (A): 1,886,794 @ $0.53 · Grant/award (A): 943,397 (derivative) @ $0EDGAR
2023-06-144McNicol Jayne — DirectorGrant/award (A): 79,787 (derivative) @ $0EDGAR
2023-04-044SAPIRSTEIN JAMES — DirectorGrant/award (A): 64,655 (derivative) @ $0EDGAR
2023-03-214Sindlev Rene — Director, 10% ownerGrant/award (A): 877,193 @ $1.14 · Grant/award (A): 438,597 (derivative) @ $0EDGAR
2023-02-064William Anderson Wittekind — 10% ownerOther (J): 1,216,467EDGAR
2023-02-064William Anderson Wittekind — 10% ownerOther (J): 97,032EDGAR
2023-02-064Weird Science LLC — 10% ownerOther (J): 17,545,283 · Other (J): 1,268,880 · Other (J): 3,631,234 · Other (J): 17,545,283 · Other (J): 61,249 · Other (J): 97,032 · +2 moreEDGAR
2023-02-064/AWilliam Anderson Wittekind — 10% ownerHoldings only — no transactions reportedEDGAR
2023-01-054Brosgart Carol L — DirectorGrant/award (A): 57,252 (derivative) @ $0EDGAR
2023-01-054Alton Gregg H — DirectorGrant/award (A): 57,252 (derivative) @ $0EDGAR
2022-10-274Binette Francois — Executive VP for R&DGrant/award (A): 40,000 (derivative) @ $0EDGAR
2022-10-274Puche Luisa — Chief Financial OfficerGrant/award (A): 80,000 (derivative) @ $0EDGAR
2022-10-264Gronfeldt-Sorensen Henrik — DirectorGrant/award (A): 45,455 (derivative) @ $0EDGAR
2022-10-254Sindlev Rene — Director, 10% ownerGrant/award (A): 32,609 (derivative) @ $0EDGAR
2022-09-154Dybul Mark — Chief Executive Officer, DirectorGrant/award (A): 350,000 (derivative) @ $0EDGAR
2022-08-034Sandler Carl ForestOther (J): 3,969,090 @ $0 · Other (J): 992,273 @ $0EDGAR
2022-07-264Puche Luisa — Chief Financial OfficerGrant/award (A): 75,000 (derivative) @ $0EDGAR
2022-07-184Sindlev Rene — Director, 10% ownerOther (J): 125,000 · Other (J): 128,493EDGAR
2022-06-134McNicol Jayne — DirectorGrant/award (A): 16,892 (derivative) @ $0EDGAR
2022-05-204Gumrukcu Serhat — 10% ownerSale (S): 125,000 @ $8 · Sale (S): 128,493 @ $8EDGAR
2022-05-204Sindlev Rene — Director, 10% ownerPurchase (P): 125,000 @ $8 · Purchase (P): 128,493 @ $8EDGAR
2022-03-244Sandler Carl Forest — Director, 10% ownerSale (S): 1,927 @ $9.06EDGAR
2022-02-234Sandler Carl Forest — Director, 10% ownerSale (S): 6,792 @ $9.03 · Sale (S): 6 @ $9EDGAR
2022-01-114/APuche Luisa — Chief Financial OfficerDisposition to issuer (D): 10,000 @ $0 · Grant/award (A): 16,266 @ $0EDGAR
2022-01-074Sandler Carl Forest — Director, 10% ownerGift (G): 2,500 @ $0 · Gift (G): 1,500 @ $0 · Gift (G): 1,500 @ $0EDGAR
2022-01-044Gronfeldt-Sorensen Henrik — DirectorGrant/award (A): 3,646 (derivative) @ $0EDGAR
2022-01-044Sindlev Rene — Director, 10% ownerGrant/award (A): 3,646 (derivative) @ $0EDGAR
2022-01-044/AGronfeldt-Sorensen Henrik — DirectorGrant/award (A): 10,519 (derivative) @ $0EDGAR
2022-01-034Brosgart Carol L — DirectorGrant/award (A): 9,458 (derivative) @ $0EDGAR
2021-12-284Alton Gregg H — DirectorGrant/award (A): 9,458 (derivative) @ $0EDGAR
2021-12-224Sindlev Rene — Director, 10% ownerGrant/award (A): 9,036 (derivative) @ $0EDGAR
2021-12-224Sandler Carl Forest Jr — Director, 10% ownerGrant/award (A): 12,712 (derivative) @ $0EDGAR
2021-12-224Gronfeldt-Sorensen Henrik — DirectorGrant/award (A): 10,519 (derivative) @ $0EDGAR
2021-12-224Alton Gregg H — DirectorGrant/award (A): 25,424 (derivative) @ $0 · Grant/award (A): 15,625 (derivative) @ $0EDGAR
2021-12-214Brosgart Carol L — DirectorGrant/award (A): 25,424 (derivative) @ $0 · Grant/award (A): 15,625 (derivative) @ $0EDGAR
2021-12-204Puche Luisa — Chief Financial OfficerGrant/award (A): 16,266 (derivative) @ $7.75 · Other (J): 15,000 (derivative) @ $6.15EDGAR
2021-11-234Puche Luisa — Chief Financial OfficerGrant/award (A): 60,000 (derivative) @ $0EDGAR
2021-07-224Dybul Mark — Chief Executive Officer, DirectorGrant/award (A): 2,000,000 (derivative) @ $0EDGAR
2021-06-254McNicol Jayne — DirectorGrant/award (A): 26,498 (derivative) @ $0EDGAR
2021-03-114SAPIRSTEIN JAMES — DirectorGrant/award (A): 19,894 (derivative) @ $0EDGAR
2021-03-114D An Evelyn — DirectorGrant/award (A): 19,894 (derivative) @ $0EDGAR
2020-12-164Dybul Mark — Executive Vice Chair, DirectorOther (J): 180 @ $0EDGAR
2020-12-164Sandler Carl Forest Jr — Director, 10% owner
William Anderson Wittekind — 10% owner
Other (J): 61,249 @ $0EDGAR

Recent 8-K events — Enochian Biosciences Inc

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-128-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-238-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-098-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-178-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-168-K8.01 — Other EventsEDGAR
2026-05-208-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-138-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-118-K/A3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2026-05-018-K1.01 — Entry into a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.02 — Unregistered Sales of Equity Securities
3.03 — Material Modification to Rights of Security Holders
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-288-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ENOB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs